Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

About Peptides.Org

About Peptides.Org Peptides.org is the leading online source for accurate and up-to-date information on peptides, empowering researchers to optimize the vast potential of these cutting-edge compounds. What We Do We are the most trusted provider of current info

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

About Peptides.Org

Peptides.org is the leading online source for accurate and up-to-date information on peptides, empowering researchers to optimize the vast potential of these cutting-edge compounds.

What We Do

We are the most trusted provider of current information on the effective use of research peptides. Founded by a pharmaceutical researcher with first-hand knowledge of the possible benefits of peptides in a range of therapeutic contexts, Peptides.org is specialized in distilling vast amounts of scientific information for researchers like you.

With a passionate belief in the exciting clinical potential of peptides, we appreciate the importance of valid information from reputable sources. Because misinformation can lead to inefficacy or even safety concerns when it comes to the administration of peptides, researchers must have access to accurate, transparent information, vetted by scientific experts.

This guides our uncompromising commitment to integrity, as we source data from far and wide, including cutting-edge clinical studies, unique use cases, and strictly peer-reviewed scientific literature. In this capacity, we equip researchers with key information to safely harness the untapped potential of peptides as alternatives to costly and invasive medical procedures.

The skilled Peptides.org team saves researchers the hassle of scanning hundreds of articles to obtain the most accurate and recent information on peptides. We know too well the challenge of finding the latest information in this rapidly evolving field.

Further, the market is saturated with inaccurate and dubious claims. In our mission to help researchers safely study the potential of peptides, we consult only trusted sources. With an unparalleled depth and breadth of specialty resources at our disposal, Peptides.org is the single most reliable online authority for the latest evidence-based information.

Our broad expertise in pharmaceutical research allows us to easily synthesize the latest information for the convenience of peptide handlers like you. From fresh breakthroughs to vanguard studies, we supply all you need to know about this budding area of therapeutics. For this reason, Peptides.org is the benchmark and industry standard for accurate, dependable, and cutting-edge information in our groundbreaking field.

About Us

Because the dynamic field is new and rapidly advancing, there are few trusted and specialized online sources for the latest information.

As accurate information on proper use is key for handlers to safely optimize the many potential benefits of therapeutic peptides, Peptides.org is committed to being the most trusted and accessible source.

The passionate team of medical professionals and seasoned clinical analysts is well-versed in proper research methods and the accurate distillation of vast amounts of scientific information for peptide handlers. Scouring the latest and leading clinical studies, peer-reviewed scientific publications, breakthroughs, and unique cases, our band of specialists provides accessible, evidence-based peptide information on our trusted site.

Our relentless dedication to accuracy coupled with our firm belief in the untapped potential of healing peptides has led Peptides.org to become the most credible and specialized source of peptide knowledge for researchers like you. Our concise information on safe and proper peptide use protects handlers from the downsides of inaccurate claims, poor research practices, and scattered sources.

In our mission as the standard-bearer for info on the latest breakthroughs in peptides, we are the go-to resource for the research community. We are pleased to introduce our distinguished team of expert medical writers who are devoted to bringing you the best information on research peptides.

David Warmflash, M.D.

David Warmflash, M.D. is a medical researcher and medical educator. His areas of expertise relevant to his role as the Peptides.org scientific director include endocrinology, cardiology, hematology, neurology, and medical genetics. He received his M.D. from Tel Aviv University and post-doctoral training at Brandeis University, University of Pennsylvania, and NASA Astrobiology Institute. Check out his full bio.

Dimitar Marinov, Ph.D.

Dr. Dimitar Marinov is a nutrition and dietetics physician, educator, and researcher with an M.D. from the Medical University of Varna. He specializes in eating disorders, metabolic health, preventative medicine, and sports medicine, conducting studies on diverse populations. Dr. Marinov has published in top scholarly journals as well as consumer platforms like WebMD, Reader's Digest, Insider, Fox News, and Healthline. Visit his complete profile.

Luis Daniel López Murillo, Ph.D.

Dr. Daniel López is a physician and esteemed professor at the University of the Valley of Mexico. He earned his Ph.D. in Pharmacological Sciences from the University of Guadalajara, where he is also currently a member of the University Center for Health Sciences faculty. His work focuses on phytopharmaceuticals, such as herbal extracts of Momordica charantia, Curcuma, and Lagerstroemia speciosa. Dr. López’s research and academic publications on plant-derived pharmaceutical agents have contributed greatly to innovations in the developing field. Learn more about Dr. López.

Dick Brashier, M.D.

Dr. Dick Brashier is an accredited regulatory advisor in Experimental and Clinical Pharmacology as well as a prolific medical researcher and writer. He specializes in pharmacovigilance and holds a medical degree in Pharmacology from the University of Poona with post-doctoral training at Harvard Medical School and the Indian Armed Forces Medical College. Dr. Brashier has published scholarly, educational, and regulatory works in a variety of clinical fields, including pioneering studies on pharmacovigilance and peptide therapeutics. Click here to explore his full background.

Glenn Bock, M.D.

Pediatric nephrologist, lecturer, and author Dr. Glenn Bock has more than 35 years of practical expertise. He earned his medical degree at the University of Missouri, Columbia, completing his pediatric residency with Upstate Medical University. His research interests are kidney therapies such as dialysis and transplantation, immunologic kidney disorders, and pediatric nephrotic syndrome. Dr. Bock's previous posts include tenured professor, department head, and fellowship director. He has written widely on his findings for peer-reviewed journals and popular websites like HealthNews and WebMD. Discover more about his experience.

Get In Touch

Peptides.org is always on the lookout for talented peptide enthusiasts to join our team.

Feel free to contact our team by filling out the form below. Also, be sure to check out our openings often, as we are a dynamic and growing team.

And if you have any questions about research peptides, feel free to reach out below:

In-Depth Peptides Research...

BPC-157​

TB-500

GHK-Cu​

Ipamorelin​

Melanotan 1

Melanotan 2

Sermorelin

Tesamorelin​

CJC-1295

Fragment 176-191

MK-677

PT-141

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Research context

Read sources and limitations before applying a claim.

Weight Management and Obesity Research

Retatrutide is a novel triple-receptor agonist that has already been tested in a couple of studies (phase 1 and phase 2) regarding its potential metabolic effects compared to previous incretin mimetics. Here is what researchers should know about these notable trials: The phase 1 study, conducted in Singapore in 2019, was the initial proof-of-concept investigation for retatrutide. It involved 47 healthy participants with a wide range of BMIs. The peptide was tested in dosages of up to 6mg/weekly for up to 12 weeks and was well tolerated amongst all participants. There was a significant reduction in appetite and improvements in metabolic parameters such as cholesterol levels [6]. Even the lowest dose of 1mg/weekly resulted in an 8.7% reduction in baseline weight, compared to a 2.1% reduction in the placebo group. The 12mg/weekly group saw the highest 24.2% reduction and 100% of the subjects receiving this dose lost at least 5% of baseline body weight. Additionally, there were significant reductions in waist circumference, blood pressure, glycated hemoglobin (HbA1c), fasting glucose and insulin levels, and non-HDL cholesterol levels [8].

Source: peptides.org ↗

Research Based

ResearchPeptides.org follows the strictest sourcing guidelines in the health and nootropics industry. Our focus is to exclusively link to peer-reviewed studies found on respected websites, like PubMed. We focus on finding the most accurate information from the scientific source. Our goal is to provide you with the most scientifically accurate, unbiased, and comprehensive information regarding all research peptides and SARMs. All of our content is written by people with a strong science background, including medical researchers. Our content is continually monitored by an internal peer-review process to ensure accuracy. We strive to never have a piece of inaccurate information on this website. If you feel that any of our content is inaccurate or out-of-date, please contact us at: [email protected] Last Updated September 8, 2025 Uncategorized September 8, 2025

Source: peptides.org ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →